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Abstract 
Purpose: To clarify the protective effects of Taurine (TA) and Coenzyme Q10 (CoQ10) for mitigation of 
acrylamide- induced oxidative damage. . 
Method: Acrylamide (AA), TA and CoQ10 were administered orally to rats for 2 and 4 weeks. Sixty 
albino rats of either sex weighing 200 ± 5  were randomly divided into five groups; control group, AA 
group, AA+ TA group, AA+ CoQ10 group and AA+ TA+ CoQ10 Group ( 15, 500 and 200 mg/kg/day 
dose, respectively). Hepatoprotection was assessed. The level of hepatic marker enzymes including 
serum lactate dehydrogenase (LDH), aspartate transaminase (AST) and alanine transaminase (ALT) 
were evaluated. The proinflammatory cytokines including serum levels of tumor necrosis factor-α (TNF-
α), interleukin- 1β (IL- 1β) and interleukin-6(IL-6) were assessed. The levels of reduced glutathione 
(GSH), malondialdehyde (MDA) and myeloperoxidase (MPO) in liver homogenate were also performed. 
Results: TA or CoQ10 significantly decreased (p < 0.05) the elevation of hepatic markers (LDH, AST 
and ALT) induced by AA in rats. Reduction of serum proinflammatory cytokines (TNF-α, IL- 1β and IL-6) 
were also observed compared to AA group, and it was a time-effect relationship. Treatment with TA or 
CoQ10 also significantly reduced the oxidative stress induced by AA as shown by an increase in GSH 
level, and reduction of MDA level and MPO activities compared to rats treated with AA alone (p < 0.05). 
The hepatoprotective effect of both TA and CoQ10 combination was more efficient than the effect of 
either of them alone. 
Conclusion: The combination of TA and Co Q10 possesses a good potential to inhibit oxidative stress 
from liver and also exhibits anti-inflammatory activity. Thus, they have the potential to be used to 
mitigate AA- induced liver injury. 
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AA (Acrylic amide; prop-2-enamide) represents 
the chemical formula C3H5NO. It is an industrial 
chemical that exists in monomer and polymer 
forms [1]. Despite rapid metabolism and 
excretion following AA exposure, its high 
reactivity with proteins could be the reason of its 
toxicity [2]. Besides industrial and laboratory 
uses, AA formation in foods has its major routes 
through Maillard reactions of reducing sugars 
(glucose) with free amino acid (asparagines) 
under high temperature and low moisture 
conditions [3]. Maillard reaction is a non-
enzymatic browning reaction in foods during 
baking or frying. Exogenous antioxidants have 
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been investigated as being potentially beneficial 
to decreasing or protecting against oxidative 
damage [4].  
 
TA is widely distributed in mammalian cells and 
tissues and has beneficial effects in various 
physiological and pathological conditions by 
mainly diminishing production of ROS. Besides, 
TA addition during food processing significantly 
inhibits acrylamide formation through directly 
reacting with AA to promote formation of AA–TA 
and AA dimmer–TA adducts [5]. Studies have 
reported that TA can prevent DNA damage at 
physiological concentrations with 
hepatoprotective effects through inhibition of 
extracellular matrix accumulation in experimental 
liver fibrosis and reverse of liver function tests in 
rats with hepatic failure. Furthermore, TA 
enhances the excretion of the hepatotoxic 
agents, inhibits thioacetamide and 
acetaminophen bio activation [6]. 
 
CoQ10 is an important cellular antioxidant found 
in all membranes. It is unique among naturally 
occurring and it is synthesized de novo in 
animals [7]. Studies have shown that the CoQ10 
has free radical-scavenging activities, liver injury-
reducing properties and endothelial dysfunction 
improving [8]. It also has anti-oxidants, anti-
fibrosis and anti- inflammatory effects [9]. 
 
Therefore, the present study investigates the 
hepatoprotective effects of TA and Co Q10 






The protocol for the present study was approved 
by the Research Ethics Committee at the Faculty 
of Science, Ain Shams University, Egypt (REC-
FS, ref no. 00033). Sixty albino rats of either sex 
weighing 200 ± 5 g were obtained from the 
Animal House Colony of the National Research 
Center, Giza, Egypt and allowed to acclimate to 
the animal facility for 2 weeks prior to the 
experiment. The rats were housed at 25 ± 2 °C 
with a 12-h light-dark cycle. The animal care and 
use was performed according to the guidelines of 
National Research Council (NRC) [10].     
 
Chemical and Drugs dose 
 
Rats were administered AA of highest purity 99.9 
% at a dose of 15 mg/kg/day. In the present 
work, the pharmacological dose of TA and 
CoQ10 was applied (500 mg/kg/day and 
200 mg/kg /day respectively). AA and TA were 
dissolved in sterile distilled water.  CoQ10 was 
prepared in a 1 % aqueous solution of Tween 80. 
All doses were administered orally for two 
intervals (two and four weeks). All chemicals 
were purchased from Sigma Chem. Co., St. 
Louis, MO, USA.  
 
Experimental design and protocol   
 
The present experiment involced two intervals - 
two and four weeks, respectively. Five groups 
were formed (n/12) for the present study (6 rats/ 
group/ interval). Group I rats received distilled 
water and served as control group. Group 2 rats 
received AA (15 mg/kg/day, orally) and served as 
AA group. Group 3 rats received TA (500 mg/kg. 
/day, orally) concomitantly with AA and served as 
AA+ TA group. Group 4 rats received CoQ10 
(200 mg/kg /day, orally) concomitantly with AA 
and served as AA+ CoQ10 group. Group 5 rats 
received both TA and CoQ10 concomitantly with 
AA and served as AA+ TA+ CoQ10 Group. . At 
the end of each experimental interval (2 and 4 
weeks), the animals were decapitated and trunk 
blood samples were collected for the biochemical 
investigations. 
 
Determination of serum LDH, AST and ALT  
 
The activities of serum LDH, AST and ALT were 
determined spectrophotometrically using an 
automated analyzer method (Opera Technician 
Bayer Auto analyzer).  
 
Determination of serum TNF- α, IL-1 β and IL-
6 
 
The level of TNF-α was assayed by ELISA 
(Sandwich Immunoassay Technique).  ]. Serum 
levels of IL- 1β and IL-6 were quantified using 
enzyme-linked immune-sorbent assay (ELISA) 
commercial kits specific for rat cytokines. The 
kits were purchased from IBL-Hamburg Co. 
(Germany). 
 
Determination of liver GSH, MDA and MPO 
 
The rats were sacrificed by decapitation; the 
livers were excised and washed in ice-cold 
isotonic saline and blotted with a filter paper. 
Subsequently, the livers were weighed and a 
portion of the tissue was homogenized in ice-cold 
150 mM KCl. The homogenate was centrifuged 
at 7000 rpm for 15min and the resulting 
supernatant was used for the determination of 
GSH and MDA levels. Commercial ELISA kit for 
determination of GSH and MDA was purchased 
from Oxford Biomedical Research Inc., USA. 
 
MPO activity was assayed by ELISA (Sandwich 
immunoassay technique) using commercial kit 
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(USCN-Life Science INC, China). 
   
Statistical analysis 
 
Data were evaluated by one-way analysis of 
variance (ANOVA), followed by the least 
significant difference (LSD) test using SPSS, 
version 10 software. P < 0.05 was considered 
statistically significant among treatments. All data 




The daily oral dose of AA (15 mg/kg) for 2 & 4 
weeks showed a significant increase (p < 0.05) in 
the enzymatic activities of serum LDH, AST, 
ALT. In addition, the serum levels of TNF-α, IL-
1β and IL- 6 showed a significant increase (p < 
0.05) in AA group compared with control group, 
indicating that the hepatotoxicity was induced by 
AA. Moreover, depletion of liver GSH was found 
in rats treated with AA compared with control (p 
< 0.05). MDA was measured as a marker of lipid 
peroxidation, and MPO was measured as a 
marker of neutrophil infiltration. It was found that 
MDA level and MPO activity were significantly 
elevated in rats treated with AA compared to 
control (p < 0.05). All adverse alterations 
increased aggressively with time. 
 
In the current investigation, amelioration effect 
occurred in the serum LDH, AST and ALT 
activities of rats group that were treated with 500 
mgTA/kg day or 200 mg CoQ10/kg /day 
individually depending on the time of treatment (2 
& 4 weeks). (Figure 1). Supplementation of TA or 
CoQ10 significantly inhibited (p < 0.05) the 
release of serum inflammatory markers and 
neutrophil infiltration as well as attenuated TNF-
α, IL-1β and IL- 6 levels (Figure 2). In contrast, 
administration of TA or CoQ10  ameliorated the 
depletion of intracellular GSH levels, modulated 
the production of MDA and significantly inhibited 
and reduced the elevated activities of MPO 
compared with AA group (Figure 3). 
 
Due to the synergistic effects of both antioxidants 
(TA & coq10), all the observed results were 
significantly reversed (p < 0.05).   The maximum 
hepatoprotective effect was observed in the rat 
groups that were treated with both antioxidants 








Figure 1: Effect of TA or CoQ10 and their combination on serum LDL (A), AST (B) and ALT (C) activities in AA-
induced oxidative stress in rats. Values are expressed as mean ± SE (n = 12). Asterisk (*) represents statistical 
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Figure 2: Effects of TA or CoQ10 and their combination on Serum TNF-α (A), IL-β (B) and IL-6 (C) levels in AA-
induced oxidative stress in rats. Values are expressed as mean ± SE, n = 12. Asterisk (*) represents statistical 




AA is a source of toxicities in humans.  Its 
creation takes place during the thermal 
processing of foods that contain amino acids, 
mainly asparagine, and reducing sugars. 
Moreover, long-term oxidative stress creates 
endogenous acrylamide formation under 
physiological conditions (37 °C, pH 7.4) where 
the majority of AA was conjugated with 
glutathione while a minimal amount was 
activated via glycidamide. Both AA and 
glycidamide can form covalent adducts with DNA 
and hemoglobin, as well as induced gene 
mutation, chromosomal aberration and malignant 
neoplasm in rodents.  Furthermore, AA and its 
bio-transformed metabolite, glycidamide, are 
hazardous to different organs such as the liver, 
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Figure 3: Effect of TA or CoQ10 and their combination on liver GSH (A), MDA (B), and MPO (C) levels in AA-
induced oxidative stress in rats. Values are expressed as mean ± SE, n = 12. Asterisk (*) represents statistical 
significance; a Compared with control b, c, d compared with AA Group; *p < 0.05 
 
testis and neurons [11]. 
 
In the present work, the activities of LDH, ALT 
and AST in AA group were significantly elevated, 
suggesting the aggressiveness of AA with time 
and confirming the advanced permeability of the 
hepatic membrane after 4 weeks, due to 
oxidative stress. 
 
Up regulation of pro-inflammatory cytokine 
expression can also be associated with the 
generation of free radicals in macrophages at the 
inflammation stage [12]. The plasma levels of the 
pro-inflammatory cytokines TNF-α, IL-1β and IL-
6 were significantly increased in AA group, 
revealing hepatic injury; as well as over 
production of ROS. In addition, significant 
increase in hepatic MDA level, end products of 
lipid peroxidation, was also observed in AA group 
suggesting a relationship between AA exposure 
and oxidative stress, and is an indicator of 
hepatic tissue damage.  
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GSH is a major intracellular antioxidant as well 
as an important component in metabolism of 
many xenobiotic. Recently, it was reported that 
AA is an oxidative stress inducer. It is efficiently 
conjugated with GSH to form glutathione-AA 
adduct that can create cellular oxidative stress. 
GSH depletion leads to increased lipid 
Peroxidation and necrosis of hepatocytes. 
Furthermore, a significant increase in the MPO 
which removes H2O2 and catalyzes the formation 
of toxic hypochlorous acid that leads to 
neutrophil infiltration and oxidative damage has 
been reported by Mustafa et al [13]. The present 
data is consistent with the previous study 
reporting that in the hepatic Caco-2 intestinal 
cells, AA induced oxidative stress through 
depletion of GSH, overproduction of ROS, and 
induction of apoptosis biomarkers that resulted in 
cell death [14]. 
 
It is interesting to observe that rats treated with 
TA had a significant improvement of LDH, AST 
and ALT enzymes, and had a significant 
suppression of TNF-α, IL-1β and IL-6; compared 
to rats treated with AA alone. The GSH content 
was significantly enhanced, while the degree of 
liver tissue damage, as measured by the level of 
MDA and MPO, was also significantly modulated 
among rats treated with TA; compared to rats 
treated with AA alone [15]. The present study 
demonstrates the antioxidant activity of TA 
against AA-induced hepatotoxicity. TA exerts its 
antioxidant effect through enhancing membrane 
stabilization with blocking tissue neutrophil 
infiltration, balancing oxidant-antioxidant status 
and regulating the generation of inflammatory 
mediators. 
 
Supplementation of CoQ10 significantly 
ameliorated liver function as indicated by LDH, 
AST and ALT levels and the production of pro 
inflammatory cytokines, as well as improved 
hepatic antioxidant defense capacity and 
attenuated ROS levels. The improvements 
recorded in all the previous parameters may be 
explained by the ability of CoQ10 to function as 
antioxidant, anti-fibrosis and anti-inflammatory 
agent against AA-induced hepatotoxicity [16]. 
 
The current investigation demonstrates that 
combination of TA and Co Q10 possesses a 
good potential to inhibit oxidative stress from liver 





TA in combination with Co Q10 exhibits 
antioxidant and anti-inflammatory effects through 
free radical- scavenging activity and creation of 
GSH levels, thereby, reducing the liver injury 
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